1,558 results on '"Lansdorp - Vogelaar, Iris"'
Search Results
2. When Should Colon Cancer Screening Begin? The Impact of Early-Onset Colorectal Cancer and the Reality of an Unscreened Older Population
3. Correction: A digital intake tool to avert outpatient visits in a FIT-based colorectal cancer screening population: study protocol of a multicentre, prospective non-randomized trial - the DIT-trial
4. A digital intake tool to avert outpatient visits in a FIT-based colorectal cancer screening population: study protocol of a multicentre, prospective non-randomized trial - the DIT-trial
5. Combining Colonoscopy With Fecal Immunochemical Test Can Improve Current Familial Colorectal Cancer Colonoscopy Surveillance: A Modelling Study
6. Fecal Hemoglobin Levels in Prior Negative Screening and Detection of Colorectal Neoplasia: A Dose-Response Meta-Analysis
7. Harm-to-Benefit Ratio of Fecal Immunochemical Test–Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations
8. When to Start, When to Stop With Colorectal Cancer Screening: A Cost-Effectiveness Analysis
9. Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis
10. Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme
11. Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening
12. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision
13. Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening
14. Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett’s Neoplasia
15. Roadmap to improve the organized cancer screening programs – The case of colorectal cancer screening in Montenegro
16. The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: A Synthetic Control Study
17. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations
18. Implementation of risk stratification within bowel cancer screening: a community jury study exploring public acceptability and communication needs
19. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
20. Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis
21. Risk of Recurrence in Screen-Detected vs Non–Screen-Detected Colorectal Cancer Patients
22. Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening
23. Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data
24. The Natural Disease Course of Pancreatic Cyst–Associated Neoplasia, Dysplasia, and Ductal Adenocarcinoma: Results of a Microsimulation Model
25. Personalised colorectal cancer screening strategies: Information needs of the target population
26. Rationale for organized Colorectal cancer screening programs
27. Development and validation of colorectal cancer risk prediction tools: A comparison of models
28. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study
29. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme
30. Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
31. Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test
32. Risk prediction for advanced neoplasia using longitudinal adherence measures to fecal immunochemical test-based colorectal cancer screening programs
33. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer
34. Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands
35. Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening
36. Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review
37. Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study
38. Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis
39. Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020.
40. Gastric Cancer Risk among Immigrants and Socioeconomic Groups in the Netherlands.
41. Optimizing screening with faecal immunochemical test for both sexes - Cost-effectiveness analysis from Finland
42. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study
43. Risk factors for advanced colorectal neoplasia and colorectal cancer detected at surveillance: a nationwide study in the modern era
44. Emulator-Based Bayesian Calibration of the CISNET Colorectal Cancer Models
45. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic
46. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer
47. The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett’s Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis
48. Colonoscopy-Related Mortality in a Fecal Immunochemical Test–Based Colorectal Cancer Screening Program
49. The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe
50. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.